What the FDA prescribing information says The FDA-approved label for semaglutide injection (Ozempic) states: "Semaglutide causes a delay in gastric emptying, and thereby has the potential to impact the absorption of concomitantly administered oral medications." [3] The Wegovy label repeats this language verbatim, and the tirzepatide (Mounjaro) label carries an equivalent warning [4]
A useful way to frame it is to compare protocol safety to signal-to-noise control in an assay
CapsiClear is derived from sustainably grown chili peppers in India, where the manufacturer Unibar works with farmers who use certified seeds, minimize crop protection, and are trained in environmentally friendly farming methods
Think of it like a supportive partner for your health journey
Methods: This study included adult patients with a clinical diagnosis of NAFLD seen at HEAWP from June 1, 2020 to June 1, 2022
Animal studies have associated early fetal exposure to incretin-based drugs with fetal growth restriction and embryotoxicity